# Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Erectile Dysfunction

> **NCT02472431** · PHASE1,PHASE2 · COMPLETED · sponsor: **Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation** · enrollment: 12 (actual)

## Conditions studied

- Erectile Dysfunction
- Impotence, Vasculogenic

## Interventions

- **OTHER:** Intracavernosal administration of autologous ADRC
- **PROCEDURE:** Liposuction
- **DEVICE:** ADRC isolation

## Key facts

- **NCT ID:** NCT02472431
- **Lead sponsor:** Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02472431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02472431, "Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Erectile Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02472431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*